Home » Topics » BioWorld Science

BioWorld Science
RSS

Origo Biopharma discloses new TGFBR1 inhibitors

April 26, 2022

Jiangsu Chia Tai Tianqing Pharmaceutical researchers synthesize new AKT inhibitors

April 26, 2022

Shenzhen Salubris Pharmaceuticals presents GLP-1 receptor agonists

April 26, 2022

Duality Biologics divulges new ADCs for cancer

April 26, 2022

BeiGene patents new MAP4K1 inhibitors

April 26, 2022

Discovery of novel oridonin analogues as potent anticancer agents

April 26, 2022

ZLD-2218, a novel BRD4 inhibitor for the treatment of kidney fibrosis

April 26, 2022

TNIK as novel therapeutic target in lung squamous cell carcinoma

April 26, 2022

CDK4/6 inhibitor PRT-3645 prolongs survival in glioblastoma and brain-metastatic breast cancers

April 26, 2022

AMG-794, a CLDN6-targeting BiTE for treating lung and ovarian tumors

April 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...